Stock Value
Competitors
| Ticker | Price | Forecast 1Y | Forecast 2Y | Market Cap | Div Yld | Growth Rate |
|---|---|---|---|---|---|---|
|
SWX:NOVN
Novartis
|
88.87 | 13.6% | 27.68% | 181,473.74 | 3.69% | 4.67% |
|
NYSE:PFE
Pfizer
|
25.64 | 19.53% | 52.98% | 147,226.07 | 6.61% | -9.31% |
|
NasdaqGS:REGN
Regeneron Pharmaceuticals
|
892.48 | -22.88% | -16.31% | 96,373.98 | 0% | 13.9% |
|
TSE:4503
Astellas Pharma
|
1506.00 | 0% | 0% | 2,700,237.55 | 4.91% | 0% |
|
XTRA:AFX
Carl Zeiss Meditec
|
100.70 | 52.87% | 93.6% | 8,738.34 | 1.1% | 18.47% |
|
NasdaqGS:IART
Integra LifeSciences Holdings
|
29.24 | 131.93% | 156.96% | 2,227.59 | 0% | 5.08% |
|
NasdaqGS:ANIK
Anika Therapeutics
|
25.97 | -,124.8% | -73.41% | 378.86 | 0% | 0% |
|
NasdaqGS:UTMD
Utah Medical Products
|
73.10 | 0% | 0% | 299.25 | 1.47% | 9.67% |
|
ENXTPA:LBIRD
Lumibird
|
12.35 | 84.37% | 139.68% | 273.8 | 0% | -8.34% |
|
NasdaqCM:FONR
FONAR
|
22.17 | 0% | 0% | 125.26 | 0% | -9.61% |
|
NasdaqCM:AVGR
Avinger
|
3.77 | 0% | 0% | 5.92 | 0% | 0% |
|
NasdaqCM:BIOL
BIOLASE
|
0.15 | 0% | 0% | 2.82 | 0% | 0% |
